Skip to main content

Animations

MJFF Publications

6171 - 6180 of 8620 Results
Title
Year
  • Year
  • 2022
  • 2018
  • 2016
  • 2020
  • 2020
  • 2021
  • 2014
  • 2020
  • 2020
  • 2022
  • Summary Details
    OPEN
    Title: The Interaction betweenHLA‐DRB1and Smoking in Parkinson's Disease Revisited
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.29133
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Portrait of blood-derived extracellular vesicles in patients with Parkinson’s disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.11.002
    Best OA location URL:
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Predictors of time to initiation of symptomatic therapy in early Parkinson's disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.317
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Impact ofGBA1variants on long-term clinical progression and mortality in incident Parkinson’s disease
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1136/jnnp-2020-322857
    Citation Count: 76
  • Summary Details
    OPEN
    Title: Potential sources of interference with the highly sensitive detection and quantification of alpha‐synuclein seeds by qRT‐QuIC
    Journal Name: FEBS Open Bio
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/2211-5463.12844
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Blood–brain barrier permeability in Parkinson’s disease patients with and without dyskinesia
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00415-021-10411-1
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011
    Citation Count: 69
  • Summary Details
    OPEN
    Title: A rapid α‐synuclein seed assay of Parkinson’s disease CSF panel shows high diagnostic accuracy
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51280
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-020-74195-6
    Citation Count: 36
  • Summary Details
    OPEN
    Title: APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00411-x
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.